신생쥐에서 유발시킨 저산소 허혈 뇌손상에 대한 melatonin과 저체온치료 병용요법의 효과
The Effect of Combination Treatment of Melatonin and Hypothermia on Hypoxic-Ischemic Brain Injury in Neonatal Rats
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
목적: Melatonin은 송과샘에서 분비되는 호르몬으로, 여러 조직에 있어 다양한 약리작용을 나타낸다. 특히, melatonin은 우수한 항산화 효과와 신경 보호작용을 가진다고 알려져 있다. 저체온치료는 저산소 허혈 뇌손상에 적용되는임상 치료법이다. 이 연구는 저산소 허혈을 유발시킨 신생쥐에서 melatonin 및 저체온치료의 병합요법의 효과에대하여 알아보고자 하였다. 방법: 생후 7일된 쥐에 저산소 허혈을 유발하였고, 실험군은 vehicle군과 melatonin 단독투여군, vehicle 및 저체온치료병합요법군, melatonin 및 저체온치료의 병합요법군으로 나누었다. Melatonin은 30 mg/kg 용량으로 복강 내 주사하였는데, 저산소 허혈 손상 직후 및 24시간 경과 시점으로 구분해서 2차례 투여하였다. 저체온치료는 전신 냉각으로 27℃ 환경에서 3시간동안 시행하였다. 정상 대조군은 저산소 허혈 뇌손상을 유발하지 않은 sham 수술군으로 하였다. 수술 후 3일(P10), 1주 경과(P14) 및 4주 시점(P35)에서 실험쥐를 희생시켜서 뇌손상을 평가하였다. 결과: TTC 염색에서 vehicle 투여한 P10 실험쥐는 저산소 허혈로 인한 뇌경색이 대조군에 비해 현저하였다. 또한, H&E염색에서 P35 실험쥐는 손상측 뇌위축이 현저하였다. Melatonin이나 저체온치료 단독으로는 뇌의 경색이나 위축을 유의하게 억제하지 못하였으나, melatonin 및 저체온요법의 병합치료는 뇌손상을 줄이는 효과가 있었다. In situ zymography 및 TUNEL 염색, 면역형광법을 이용해서 뇌손상을 평가한 결과 오직 병합요법만이 신경 보호효과를 나타내었다. 결론: Melatonin은 저산소 허혈 뇌손상에 대하여 저체온치료의 신경 보호작용에 상승효과를 가지는 것으로 보인다.
Abstract
Purpose: Melatonin is a naturally occurring hormone produced by the pineal gland. Melatonin has many pharmacological effects in different tissues or organs. Melatoninis especially known to have antioxidant and neuroprotective effects. Hypothermia is atherapeutic tool against hypoxia-ischemia (HI) of the brain. This study examines theeffect of combined therapy using melatonin and hypothermia in neonatal rats with HI. Methods: Seven-day old rats were subjected to HI and randomized into four groups :vehicle, melatonin alone, vehicle and hypothermia, and melatonin and hypothermia. Melatonin (30 mg/kg) was intraperitoneally administered in two doses: immediatelyfollowing HI, and 24 h later. Hypothermia consisted of whole-body cooling (3 hours,27℃). Sham-treated animals not subjected to HI were also studied. P10, P14, andP35 rats were sacrificed for experiments. Results: Vehicle-treated P10 rats increased in brain infarction compared to controlsin TTC staining study. And also, P35 rats decreased in brain volume of injured hemispherein H&E stain. Melatonin or hypothermia alone did not show any protectiveeffect against HI. However, a combination of melatonin and hypothermia effectivelyreduced the brain injury. In addition, the results of in situ zymography, TUNEL assayand immunofluorescence studies showed that neuroprotective effects were achievedonly with combined therapy. Conclusion: Melatonin may contribute to synergistic effects to neuroprotection ofhypothermia on brain damage after HI.
참고문헌 (37)
- Ferriero DM, "Neonatal brain injury", N Engl J Med, 351, pp.1985~1995 (2004)
- Mclean C, "Mechanisms of hypoxic-ischemic injury in the term infant", Semin Perinatol, 28, pp.425~432 (2004)
- Levene MI, "Comparison of two methods of predicting outcome in perinatal asphyxia", Lancet, 1, pp.67~69 (1986)
- Thoresen M, "Mild hypothermia after severe transient hypoxiaischemia ameliorates delayed cerebral energy failure in the newborn piglet", Pediatr Res, 37, pp.667~670 (1995)
- Bona E, "Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome", Pediatr Res, 43, pp.738~745 (1998)
- Edwards AD, "Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data", BMJ, 340, pp.c363~ (2010)
- Yager JY, "Effect of mild hypothermia on cerebral energy metabolism during the evolution of hypoxic-ischemic brain damage in the immature rat", Stroke, 27, pp.919~925 (1996)
- Gunn AJ, "Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs", J Clin Invest, 99, pp.248~256 (1997)
- Miller JA Jr, "Hypothermia in the treatment of asphyxia neonatorum", Biol Neonat, 6, pp.148~163 (1964)
- Wyatt JS, "Determinants of outcomes after head cooling for neonatal encephalopathy", Pediatrics, 119, pp.912~921 (2007)
- 김행미, "신생아 저산소 허혈 뇌증의 약물 치료적 접근", Neonatal medicine, 20(3), pp.333~340 (2013), 대한신생아학회
- Adachi M, "Combination effect of systemic hypothermia and caspase inhibitor administration against hypoxic-ischemic brain damage in neonatal rats", Pediatr Res, 50, pp.590~595 (2001)
- Alkan T, "Neuroprotective effects of MK 801 and hypothermia used alone and in combination in hypoxic-ischemic brain injury in neonatal rats", Arch Physiol Biochem, 109, pp.135~144 (2001)
- Tan DX, "One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?", J Pineal Res, 42, pp.28~42 (2007)
- Altun A, "Melatonin: therapeutic and clinical utilization", Int J Clin Pract, 61, pp.835~845 (2007)
- Bubenik GA, "Melatonin and aging: prospects for human treatment", J Physiol Pharmacol, 62, pp.13~19 (2011)
- Shinozuka K, "Melatonin-based therapeutics for neuroprotection in stroke", Int J Mol Sci, 14, pp.8924~8947 (2013)
- Fan X, "Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury", Curr Neuropharmacol, 8, pp.324~334 (2010)
- Hung YC, "Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats", J Pineal Res, 45, pp.459~467 (2008)
- Rosell A, "Multiphasic roles for matrix metalloproteinases after stroke", Curr Opin Pharmacol, 8, pp.82~89 (2008)
- Asahi M, "Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood brain barrier and white matter components after cerebral ischemia", J Neurosci, 21, pp.7724~7732 (2001)
- Tai SH, "Melatonin protects against transient focal cerebral ischemia in both reproductively active and estrogen-deficient female rats: the impact of circulating estrogen on its hormetic doseresponse", J Pineal Res, 50, pp.292~303 (2011)
- Lee SR, "Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia", J Neurosci, 24, pp.671~678 (2004)
- Pei Z, "Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model", J Pineal Res, 32, pp.168~172 (2002)
- González-Burgos I, "Long-term study of dendritic spines from hippocampal CA1 pyramidal cells, after neuroprotective melatonin treatment following global cerebral ischemia in rats", Neurosci Lett, 423, pp.162~166 (2007)
- Chung SY, "Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition", J Pineal Res, 34, pp.95~102 (2003)
- Espinar A, "Neuroprotection by melatonin from glutamateinduced excitotoxicity during development of the cerebellum in the chick embryo", J Pineal Res, 28, pp.81~88 (2000)
- Carloni S, "Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats", J Pineal Res, 44, pp.157~164 (2008)
- Gupta YK, "Enhanced protection by melatonin and meloxicam combination in a middle cerebral artery occlusion model of acute ischemic stroke in rat", Can J Physiol Pharmacol, 80, pp.210~217 (2002)
- Huh PW, "Comparative neuroprotective efficacy of prolonged moderate intraischemic and postischemic hypothermia in focal cerebral ischemia", J Neurosurg, 92, pp.91~99 (2000)
- Liu Yi, "Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats", Stroke, 35, pp.1460~1465 (2004)
- Shankaran S, "Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy", N Engl J Med, 353, pp.1574~1584 (2005)
- Gluckman PD, "Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial", Lancet, 365, pp.663~670 (2005)
- Robertson NJ, "Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model", Brain, 136, pp.90~105 (2013)
- Rosenberg GA, "Matrix metalloproteinases in brain injury", J Neurotrauma, 12, pp.833~842 (1995)
- Candelario-Jalil E, "Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia", Neuroscience, 158, pp.983~994 (2009)
- Chen W, "Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain", J Neurochem, 111, pp.726~736 (2009)
